Home › Trial NCT00186238
High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma
- Trial IDNCT00186238
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorStanford University
- Enrollment300
- Start date1994-09
- ConditionsMultiple Myeloma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.